Results 231 to 240 of about 599,368 (371)
Obesity‐related glomerulopathy: How it happens and future perspectives
Abstract Obesity‐related glomerulopathy (ORG) is an emerging complication of excess adiposity. Its incidence rises alongside the obesity pandemic. Up to 40% of individuals can be affected by ORG, irrespective of the status of glomerular filtration rate and albuminuria.
Jian‐Wen Samuel Lee‐Boey+7 more
wiley +1 more source
Inflammation in atherosclerotic cardiovascular disease: From diagnosis to treatment
Inflammation in atherosclerotic cardiovascular disease. Residual inflammatory risk (RIR), defined by high‐sensitive C‐reactive protein (hsCRP) concentration of ≥2 mg/L, represents a strong predictor of future atherosclerotic cardiovascular disease (ASCVD) events. Although increased hsCRP values ≥2 mg/L might be detected in every three out of five ASCVD
Natalie Arnold, Wolfgang Koenig
wiley +1 more source
Enhanced fibrinolysis caused by tissue plasminogen activator release in hemodialysis
Wolfgang Speiser+4 more
openalex +1 more source
BackgroundLimited studies exist on the outcome of thrombolytic therapy of acute ischemic stroke patients outside of clinical trials.AimTo assess the possible risk factors associated with in-hospital death and symptomatic intracerebral hemorrhage among ...
core
We studied the impact of circadian misalignment on 238 plasma proteins linked to cardiovascular physiology. We identified 42 proteins with altered abundance, five proteins regulated by the circadian clock, and changes in many proteins in the coagulation pathway.
Andrew W. McHill+3 more
wiley +1 more source
Obesity, white adipose tissue and cancer
White adipose tissue (WAT) is essential for energy balance and hormone regulation. In obesity, WAT becomes dysfunctional, leading to inflammation and other changes that promote different stages of carcinogenesis. This review explores how unhealthy WAT under obese conditions supports carcinoma growth through both systemic effects and modulation of the ...
Estel Solsona‐Vilarrasa+1 more
wiley +1 more source
STROKE: Vascular and Interventional Neurology, EarlyView.
Jonathan Sukovich+2 more
wiley +1 more source
Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen. [PDF]
Jeffrey I. Weitz+6 more
openalex +1 more source
ABSTRACT Introduction Type 1 plasminogen deficiency (PLGD‐1), or hypoplasminogenaemia, is an ultra‐rare autosomal‐recessive disorder characterised by fibrin‐rich lesions on mucous membranes, often leading to serious complications if left untreated. Prior treatments have shown limited and inconsistent success, but IV PLG concentrate (Ryplazim) offers a ...
Amy D. Shapiro+7 more
wiley +1 more source